New paths for drug discovery and design 🧪

Understanding what individual proteins do is crucial for most drug development

Subscribe Weekend Reads Technology in Perspective 06.17.23 | Protein foldings Understanding what individual proteins do is crucial for most drug development and for understanding many diseases. DeepMind has opened new paths for drug discovery and design by solving a 50-year-old problem in biology. Read on to explore how DeepMind shifted from playing games to solving one of the hardest problems in science. Plus, give your dad a year of MIT Technology Review this Father's Day. With unlimited access to emerging technology news, in-depth reporting, and expert insights, they'll never run out of stories to read or share. AI for protein folding DeepMind has opened new paths for drug discovery and design by solving a 50-year-old problem in biology. An AI that can design new proteins could help unlock new cures and materials The machine-learning tool could help researchers discover entirely new proteins not yet known to science. DeepMind has predicted the structure of almost every protein known to science And it's giving the data away for free, which could spur new scientific discoveries. This is the reason Demis Hassabis started DeepMind A year after it took biologists by surprise, AlphaFold has changed how researchers work and set DeepMind on a new course. DeepMind says it will release the structure of every protein known to science The company has already used its protein-folding AI, AlphaFold, to generate structures for the human proteome, as well as yeast, fruit flies, mice, and more. DeepMind's protein-folding AI has solved a 50-year-old grand challenge of biology AlphaFold can predict the shape of proteins to within the width of an atom. The breakthrough will help scientists design drugs and understand disease. Celebrate this Father's Day by gifting your dad a year of MIT Technology Review. With unlimited access to emerging technology news, in-depth reporting, and expert insights, they'll never run out of stories to read or share. GIVE A GIFT & SAVE Was this newsletter forwarded to you, and you'd like to see more? Sign up today → View in browser | This email was sent to alexvarboffin.abbb@blogger.com. Manage your preferences | Unsubscribe | Terms of Service | Privacy Policy MIT Technology Review · 196 Broadway, 3rd fl, · Cambridge, MA 02139 · USA Copyright © 2023 MIT Technology Review, All rights reserved. Opt out of all promotional emails and newsletters from MIT Technology Review